Assessment reports on the state of play of drug policy making in Central Asia have been published by CADAP

Assessment reports on the state of play of drug policy making in Central Asia have been published by CADAP

For the first time, the Central Asia Drug Action Programme Phase 6 (CADAP 6) sets out proposals for reviewing and supporting the development of strategies, action plans and legislations employing European good practices. The Trimbos-instituute incorporates a balanced policy approach with the latest developments and achievements in the field of drug demand reduction and other drug-related policy forms (including new approaches supported by CADAPs’ previous phases) and overarches the actions covered by the other components, namely national focal points, drug use prevention mechanisms, prevention campaigns, treatment methodologies and social/street work. Trimbos’ strategy follows an integrated and plural approach to drug policy by inter-agency coordination, trans-regional and international cooperation.

CADAP 6 strengthens beneficiary countries’ institutions along with organizational, technical and legal capacities. This improves the general conditions on which a sustainable response to the drug phenomenon in the region can be built. By strengthening leadership and ownership of the partners’ countries stakeholders and decision makers (both from the demand side and from the supply side – the two core constituents of drug policy) the prerequisites for a sustained engagement of key players are being created. In the current implementation phase, CADAP has presented experiences of EU Member States, case studies of policy making process and policy implementation through seminars and workshops at regional and national conferences. Furthermore, the considerable experience of national partners has been mobilized and encouraged by collecting and exchanging the already available knowledge.

This present report has used data and information which was gathered from literature, other information sources and interviews, and reflects the opinions and ideas of the authors.  It does not represent in any form the official stance of the Central Asian governments in relation to the topics contained in the text. The report should foster regional exchange of expertise, learning and discourse on the applied policies and practices, aiming to increase effective drug policies based on evidence and human rights.

Back to list